Omega Therapeutics, Inc.
OMGA · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $30 | $46 | $60 | $68 |
| Short-Term Investments | $0 | $0 | $0 | $5 |
| Receivables | $0 | $1 | $1 | $7 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $8 | $9 | $10 | $9 |
| Total Curr. Assets | $39 | $56 | $71 | $90 |
| Property Plant & Equip (Net) | $114 | $112 | $112 | $114 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $114 | $112 | $113 | $114 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $153 | $168 | $184 | $204 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $2 | $2 |
| Short-Term Debt | $16 | $28 | $16 | $15 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | -$9 | $2 | $0 |
| Other Curr. Liab. | $7 | -$4 | $5 | $10 |
| Total Curr. Liab. | $24 | $26 | $25 | $27 |
| LT Debt | $112 | $111 | $112 | $113 |
| Deferred Rev, NC | $0 | $0 | $4 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $98 | $0 |
| Other NC Liab. | $5 | $5 | $2 | $6 |
| Total NC Liab. | $117 | $116 | $118 | $120 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $113 | $110 | $110 | $110 |
| Total Liabilities | $141 | $142 | $142 | $146 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$388 | -$371 | -$355 | -$335 |
| AOCI | $0 | $0 | -$0 | -$0 |
| Other Equity | $399 | $397 | $396 | $393 |
| Total Equity | $12 | $26 | $41 | $58 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $153 | $168 | $184 | $204 |
| Net Debt | $98 | $93 | $68 | $60 |